<DOC>
	<DOC>NCT01710371</DOC>
	<brief_summary>To evaluate 18F-AV-133 imaging of the pancreas in patients with early type 2 diabetes, late type 2 diabetes, subjects with pre-diabetes and in healthy overweight/obese control subjects. These subjects will also be evaluated for beta-cell function as measured by the insulin and C-peptide response to a challenge with intravenous arginine under basal and glucose enhanced conditions.</brief_summary>
	<brief_title>Quantitative 18F-AV-133 PET Imaging in Subjects With Diabetes and Healthy Controls</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Male and/or female subjects of nonchildbearing potential between the ages of 30 and 65 years inclusive. Able to tolerate PET, PET/CT and MR imaging Estimated creatinine clearance &gt;= 60mL/min Informed consent documents signed and dated by subject Subjects must be willing and able to comply with all scheduled visits, treatments laboratory tests, scans and other study procedures. In addition, subjects must meet classification requirements for one of the following 1. Healthy Overweight 2. Prediabetes 3. T2DM (T2DM only) Subjects with other chronic medical conditions (besides diabetes) that are well controlled and stable on medication are acceptable for inclusion in this study. Subjects who are affiliated with or relatives of staff members of either the site or Pfizer directly involved in the conduct of the trial. Conditions which in the opinion of the study investigator may interfere with the subject's ability to participate in the study History of allergic reaction to drug/contrast agent or history of drug/alcohol abuse Subjects who have received investigational medications within the last 30 days or a radiopharmaceutical in the past 7 days. Pregnant or nursing females; females of childbearing potential.</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>